Donald L. Hagan, LLC Bristol Myers Squibb CO Transaction History

Donald L. Hagan, LLC

$178 Million
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	SELL	$57.89 - $64.73 $149,703 - $167,391	-2,586 Reduced 9.96%	23,378 $1.36 Million
Q2 2023 Jul 17, 2023	SELL	$63.71 - $70.74 $50,394 - $55,955	-791 Reduced 2.96%	25,964 $1.66 Million
Q1 2023 Apr 18, 2023	BUY	$65.71 - $74.53 $321,321 - $364,451	4,890 Added 22.36%	26,755 $1.85 Million
Q4 2022 Jan 17, 2023	BUY	$68.48 - $81.09 $100,802 - $119,364	1,472 Added 7.22%	21,865 $0
Q3 2022 Oct 12, 2022	BUY	$0.13 - $76.84 $57 - $33,963	442 Added 2.22%	20,393 $1.45 Million
Q2 2022 Jul 20, 2022	SELL	$72.62 - $79.98 $71,675 - $78,940	-987 Reduced 4.71%	19,951 $1.54 Million
Q1 2022 Apr 18, 2022	BUY	$61.48 - $73.72 $29,756 - $35,680	484 Added 2.37%	20,938 $1.53 Million
Q4 2021 Jan 20, 2022	BUY	$53.63 - $62.52 $830,085 - $967,684	15,478 Added 311.05%	20,454 $1.28 Million
Q3 2021 Oct 20, 2021	BUY	$59.17 - $69.31 $38,282 - $44,843	647 Added 14.95%	4,976 $294,000
Q1 2021 Apr 27, 2021	SELL	$59.34 - $66.74 $43,852 - $49,320	-739 Reduced 14.58%	4,329 $273,000
Q4 2020 Jan 15, 2021	SELL	$57.74 - $65.43 $69,288 - $78,516	-1,200 Reduced 19.14%	5,068 $314,000
Q3 2020 Oct 16, 2020	BUY	$57.43 - $63.64 $24,694 - $27,365	430 Added 7.37%	6,268 $378,000
Q2 2020 Aug 03, 2020	SELL	$54.82 - $64.09 $3,837 - $4,486	-70 Reduced 1.18%	5,838 $343,000
Q1 2020 Apr 17, 2020	BUY	$46.4 - $67.43 $881 - $1,281	19 Added 0.32%	5,908 $351,000
Q4 2019 Jan 24, 2020	BUY	$49.21 - $64.19 $51,129 - $66,693	1,039 Added 21.42%	5,889 $397,000
Q3 2019 Oct 21, 2019	BUY	$42.77 - $50.71 $12,831 - $15,213	300 Added 6.59%	4,850 $250,000
Q2 2019 Jul 18, 2019	SELL	$44.62 - $49.34 $91,738 - $101,443	-2,056 Reduced 31.12%	4,550 $206,000
Q1 2019 Apr 25, 2019	SELL	$45.12 - $53.8 $5,414 - $6,456	-120 Reduced 1.78%	6,606 $315,000
Q2 2018 Jul 19, 2018	BUY	$50.53 - $62.98 $6,063 - $7,557	120 Added 1.82%	6,726 $372,000
Q4 2017 Jan 12, 2018	SELL	$59.94 - $65.35 $11,988 - $13,069	-200 Reduced 2.94%	6,606 $405,000
Q3 2017 Oct 24, 2017	BUY	$55.23 - $63.74 $375,895 - $433,814	6,806	6,806 $434,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Donald L. Hagan, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donald L. Hagan, LLC with notifications on news.

Account